Industries > Pharma > Next Generation Sequencing Market Report 2023-2033

Next Generation Sequencing Market Report 2023-2033

Forecasts by Type (Consumables, Bioinformatics, Sequencing Services, Pre-sequencing Services, Instruments), by Workflow (Library Preparation, Sequencing, Data Analysis), by Application (Oncology, Reproductive Health, Genetic and Rare Diseases, Consumer Genomics, Agrigenomics & Forensics, Others), by End-use (Hospitals and Clinics, Academic and Research Institutes, Pharmaceutical and Biotech Companies, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis

PUBLISHED: 24 July 2023
PAGES: 242
PRODUCT CODE: PHA1270

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA1270 Categories: , Tag:

The Next Generation Sequencing Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Decreasing Cost, Speed and Efficiency and High Throughput Driving Market Growth
One of the primary drivers of NGS technology is the continuous reduction in sequencing costs. Over the years, the cost of sequencing has dramatically decreased, making it more accessible and affordable for researchers and clinicians. This cost reduction has enabled large-scale sequencing projects and made personalized genomics and precision medicine initiatives more feasible. NGS technology offers rapid turnaround times compared to traditional sequencing methods. It can generate billions of DNA fragments in parallel, allowing for faster data generation. The speed and efficiency of NGS have enabled real-time sequencing and the timely analysis of genomic information in clinical settings, aiding in the diagnosis of genetic disorders and informing treatment decisions. In addition, NGS technology allows for high-throughput sequencing, meaning it can process a large volume of DNA or RNA samples simultaneously. High-throughput sequencing has facilitated large-scale population studies, cancer genomics, and microbiome research, among other applications. The aforementioned factors are driving the next generation sequencing market growth.

Lack of Skilled Professional to Hamper Industry Growth
NGS technology requires specialized skills and expertise in sample preparation, library construction, data analysis, and interpretation. The lack of access to training programs and limited availability of qualified personnel proficient in NGS can hinder the widespread adoption and utilization of the technology. NGS technology requires a combination of expertise in molecular biology, genetics, bioinformatics, and data analysis. Finding professionals who possess the necessary interdisciplinary knowledge and skills can be challenging, as traditional training programs may not provide comprehensive education in all these areas.

What Questions Should You Ask before Buying a Market Research Report?
• How is the next generation sequencing market evolving?
• What is driving and restraining the next generation sequencing market?
• How will each next generation sequencing submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each next generation sequencing submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading next generation sequencing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the next generation sequencing projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of
next generation sequencing projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the next generation sequencing manufacturing market?
• Where is the next generation sequencing market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the next generation sequencing market today, and over the next 10 years:
• Our 24-page report provides 102 tables and 139 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the next generation sequencing market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges) and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Type Outlook
• Consumables
• Bioinformatics
• Sequencing Services
• Pre-sequencing Services
• Instruments

Workflow
• Library Preparation
• Sequencing
• Data Analysis

Application
• Oncology
• Reproductive Health
• Genetic and Rare Diseases
• Consumer Genomics
• Agrigenomics & Forensics
• Others

End-use
• Hospitals and Clinics
• Academic and Research Institutes
• Pharmaceutical and Biotech Companies
• Others

CTA

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 24 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of Latin America

MEA
• GCC
• South Africa
• Rest of MEA

Next Generation Sequencing Market Report 2023-2033
Need industry data? Please contact us today.

The report also includes profiles and for some of the leading companies in the Next Generation Sequencing Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Eurofins Scientific
• F. Hoffman-La Roche Ltd
• Illumina, Inc.
• PerkinElmer Inc.
• QIAGEN
• Thermo Fisher Scientific Inc.

Overall world revenue for Next Generation Sequencing Market, 2023 to 2033 in terms of value the market will surpass US$10,626 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Next Generation Sequencing Market, 2023 to 2033 report help you?
In summary, our 240+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Next Generation Sequencing Market, 2023 to 2033 Market, with forecasts for type, workflow, application, and end-user, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for five regional and 24 key national markets – See forecasts for the Next Generation Sequencing Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Argentina, Colombia, Germany, France, UK, Italy, China, India, Japan, Singapore, South Korea, GCC Countries, South Africa, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 8 of the major companies involved in the Next Generation Sequencing Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Next Generation Sequencing Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Next Generation Sequencing Market Report 2023-2033: Forecasts by Type (Consumables, Bioinformatics, Sequencing Services, Pre-sequencing Services, Instruments), by Workflow (Library Preparation, Sequencing, Data Analysis), by Application (Oncology, Reproductive Health, Genetic and Rare Diseases, Consumer Genomics, Agrigenomics & Forensics, Others), by End-use (Hospitals and Clinics, Academic and Research Institutes, Pharmaceutical and Biotech Companies, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Next Generation Sequencing Market Report 2023-2033

    Download sample pages

    Complete the form below to download your free sample pages for Next Generation Sequencing Market Report 2023-2033

      Latest Pharma news

      Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034

      The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.

      23 April 2024

      READ

      Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

      The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

      18 April 2024

      READ

      Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

      The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

      17 April 2024

      READ

      Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

      The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

      12 April 2024

      READ